This month, Hoosier Cancer Research Network (HCRN) features our member Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Nasser Hanna, MD, a medical oncologist and researcher at the cancer center. Dr. Hanna is a former chairman of the HCRN board of directors and a current member of the HCRN Thoracic Clinical Trial Working Group.

Research Interests and Expertise

The majority of my research has been in the field of lung cancer. My recent focus has been on the incorporation of immunotherapy for earlier stages of lung cancer and to tailor the duration of therapy based upon circulating tumor DNA as a marker for minimal residual disease.

Educational Background

• MD, University of Missouri
• Residency (Internal Medicine), University of Iowa
• Fellowship (Oncology), Indiana University

Little-Known Facts

• I am a lifelong St. Louis Cardinals baseball fan.
• Schindler’s List is the most impactful movie I’ve ever seen.
• My heroes are RFK, MLK and John Lewis.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 210 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 8,500 subjects have participated in Hoosier Cancer Research Network clinical trials.